BNED vs HBB

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no Altman Z-Score available, leaving bankruptcy risk unconfirmed but concerning given high leverage. Despite a low current P/E of 12.89 compared to sector average of 53.76, the negative forward P/E (-0.25) and collapsing earnings growth (-62% YoY) signal deteriorating profitability. The stock trades above the Graham Number of $11.53 but well above the intrinsic value of $4.97, suggesting overvaluation on a conservative basis. Persistent negative earnings surprises, declining ROE, and weak insider sentiment (40/100) further undermine confidence in a near-term turnaround.

HBB presents a classic value-trap profile, characterized by a weak Piotroski F-Score of 3/9 indicating deteriorating financial health. While the stock trades below its Graham Number ($24.46), suggesting defensive value, it sits significantly above its growth-based intrinsic value ($13.65). This valuation gap is exacerbated by negative year-over-year revenue (-0.30%) and earnings growth (-21.20%). Despite strong short-term price momentum, the underlying fundamentals and a bearish technical trend score suggest limited long-term upside without a turnaround in growth.